Seoulin Bioscience Co.Ltd - Asset Resilience Ratio

Latest as of September 2025: 19.60%

Seoulin Bioscience Co.Ltd (038070) has an Asset Resilience Ratio of 19.60% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Seoulin Bioscience Co.Ltd (038070) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

₩22.26 Billion
≈ $15.08 Million USD Cash + Short-term Investments

Total Assets

₩113.52 Billion
≈ $76.93 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Seoulin Bioscience Co.Ltd's Asset Resilience Ratio has changed over time. See 038070 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Seoulin Bioscience Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Seoulin Bioscience Co.Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩22.26 Billion 19.6%
Total Liquid Assets ₩22.26 Billion 19.60%

Asset Resilience Insights

  • Good Liquidity Position: Seoulin Bioscience Co.Ltd maintains a healthy 19.60% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Seoulin Bioscience Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Seoulin Bioscience Co.Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Royalty Pharma Plc
NASDAQ:RPRX
Biotechnology 0.10%
Ascendis Pharma AS
NASDAQ:ASND
Biotechnology 0.00%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 3.28%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 4.52%
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
Biotechnology 35.56%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
Neuren Pharmaceuticals Ltd
AU:NEU
Biotechnology 90.43%
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488
Biotechnology 4.35%

Annual Asset Resilience Ratio for Seoulin Bioscience Co.Ltd (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Seoulin Bioscience Co.Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 22.02% ₩22.36 Billion
≈ $15.15 Million
₩101.52 Billion
≈ $68.80 Million
-6.79pp
2023-12-31 28.81% ₩32.88 Billion
≈ $22.28 Million
₩114.10 Billion
≈ $77.32 Million
-10.33pp
2022-12-31 39.14% ₩52.79 Billion
≈ $35.78 Million
₩134.87 Billion
≈ $91.40 Million
-14.52pp
2021-12-31 53.66% ₩73.28 Billion
≈ $49.66 Million
₩136.57 Billion
≈ $92.55 Million
+29.56pp
2020-12-31 24.10% ₩18.86 Billion
≈ $12.78 Million
₩78.25 Billion
≈ $53.03 Million
-3.21pp
2019-12-31 27.30% ₩22.04 Billion
≈ $14.93 Million
₩80.71 Billion
≈ $54.69 Million
+13.63pp
2018-12-31 13.68% ₩9.73 Billion
≈ $6.59 Million
₩71.11 Billion
≈ $48.19 Million
-1.55pp
2017-12-31 15.23% ₩10.82 Billion
≈ $7.33 Million
₩71.04 Billion
≈ $48.14 Million
-9.54pp
2016-12-31 24.77% ₩16.46 Billion
≈ $11.16 Million
₩66.47 Billion
≈ $45.05 Million
-4.59pp
2015-12-31 29.36% ₩19.41 Billion
≈ $13.15 Million
₩66.10 Billion
≈ $44.80 Million
-2.45pp
2014-12-31 31.81% ₩19.32 Billion
≈ $13.09 Million
₩60.72 Billion
≈ $41.15 Million
-1.62pp
2013-12-31 33.44% ₩20.19 Billion
≈ $13.68 Million
₩60.39 Billion
≈ $40.92 Million
--
pp = percentage points

About Seoulin Bioscience Co.Ltd

KQ:038070 Korea Biotechnology
Market Cap
$37.75 Million
₩55.70 Billion KRW
Market Cap Rank
#22893 Global
#1589 in Korea
Share Price
₩6310.00
Change (1 day)
-0.47%
52-Week Range
₩6050.00 - ₩8390.00
All Time High
₩36786.63
About

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and fun… Read more